Fig. 2: Near-infrared fluorescence enhanced microarray detection of biomarkers.
From: Diagnosis and prognosis of myocardial infarction on a plasmonic chip
a Fluorescence mapping results by IRDye800 labeled detection of cTnI (0–1.2 ng mL−1) on pGold (left), glass (middle), and sGold (right) chips. b Calibration curves comparing detection limits and dynamic ranges for cTnI on pGold (red), glass (blue), and sGold (yellow) chips. We performed three independent experiments on pGold, glass, and sGold chips to calculate the standard deviation (s.d.) as error bars and data are shown as the mean ± s.d. (n = 3). c Calibration curve of cTnI quantification by CIA. We performed three independent CIA experiments and data are shown as the mean ± s.d. (n = 3). Similarly, d fluorescence mapping results, e calibration curves comparing detection limits and dynamic ranges by different chips, and f calibration curve by CIA were obtained for CK-MB. We performed three independent experiments and data are shown as the mean ± s.d. (n = 3). All samples used for the calibration curves were standards containing known concentrations of biomarkers provided by the vendor (Tellgen). Source data are provided as a Source Data file.
